Physiological Roles of the von Willebrand Factor-Factor VIII Interaction
- PMID: 32189311
- DOI: 10.1007/978-3-030-41769-7_18
Physiological Roles of the von Willebrand Factor-Factor VIII Interaction
Abstract
Von Willebrand factor (VWF) and coagulation factor VIII (FVIII) circulate as a complex in plasma and have a major role in the hemostatic system. VWF has a dual role in hemostasis. It promotes platelet adhesion by anchoring the platelets to the subendothelial matrix of damaged vessels and it protects FVIII from proteolytic degradation. Moreover, VWF is an acute phase protein that has multiple roles in vascular inflammation and is massively secreted from Weibel-Palade bodies upon endothelial cell activation. Activated FVIII on the other hand, together with coagulation factor IX forms the tenase complex, an essential feature of the propagation phase of coagulation on the surface of activated platelets. VWF deficiency, either quantitative or qualitative, results in von Willebrand disease (VWD), the most common bleeding disorder. The deficiency of FVIII is responsible for Hemophilia A, an X-linked bleeding disorder. Here, we provide an overview on the role of the VWF-FVIII interaction in vascular physiology.
Keywords: Acute phase protein; Coagulation factor VIII (FVIII); Hemophilia; Hemostasis; Platelet; von Willebrand factor (VWF).
Similar articles
-
The factor VIII/von Willebrand factor complex: basic and clinical issues.Haematologica. 2003 Jun;88(6):EREP02. Haematologica. 2003. PMID: 12826528 Review.
-
Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.Am J Hematol. 1998 Aug;58(4):311-8. doi: 10.1002/(sici)1096-8652(199808)58:4<311::aid-ajh11>3.0.co;2-a. Am J Hematol. 1998. PMID: 9692396
-
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A.Blood. 1993 May 15;81(10):2644-51. Blood. 1993. PMID: 8490173
-
Interaction between VWF and FVIII in treating VWD.Eur J Haematol. 2015 Nov;95(5):449-54. doi: 10.1111/ejh.12514. Epub 2015 Feb 19. Eur J Haematol. 2015. PMID: 25605439 Review.
-
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.J Thromb Haemost. 2017 Aug;15(8):1607-1619. doi: 10.1111/jth.13749. Epub 2017 Jul 17. J Thromb Haemost. 2017. PMID: 28581694
Cited by
-
Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.J Thromb Haemost. 2022 Jul;20(7):1674-1683. doi: 10.1111/jth.15741. Epub 2022 May 22. J Thromb Haemost. 2022. PMID: 35466511 Free PMC article.
-
Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour.Cancers (Basel). 2024 Jun 27;16(13):2356. doi: 10.3390/cancers16132356. Cancers (Basel). 2024. PMID: 39001418 Free PMC article.
-
Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for Cushing's disease.Sci Rep. 2023 Feb 24;13(1):3217. doi: 10.1038/s41598-023-30070-8. Sci Rep. 2023. PMID: 36828936 Free PMC article.
-
Thromboembolic Events in the Era of COVID-19: A Detailed Narrative Review.Can J Infect Dis Med Microbiol. 2025 Mar 4;2025:3804576. doi: 10.1155/cjid/3804576. eCollection 2025. Can J Infect Dis Med Microbiol. 2025. PMID: 40226433 Free PMC article. Review.
-
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025. Front Oncol. 2025. PMID: 40666093 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous